NanoViricides, Inc. logo

NanoViricides, Inc.

AMEX:NNVC

Overview | Financials
Company Name NanoViricides, Inc.
Symbol NNVC
Currency USD
Price 1.1
Market Cap 12,832,600
Dividend Yield 0%
52-week-range 1 - 2
Industry Biotechnology
Sector Healthcare
CEO Dr. Anil R. Diwan Ph.D.
Website https://www.nanoviricides.com

An error occurred while fetching data.

About NanoViricides, Inc.

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and

Related Stocks

BiomX Inc. logo

BiomX Inc.

PHGE

0.41 USD

AgeX Therapeutics, Inc. logo

AgeX Therapeutics, Inc.

AGE

0.43 USD

Timber Pharmaceuticals, Inc. logo

Timber Pharmaceuticals, Inc.

TMBR

1.461 USD

American Shared Hospital Services logo

American Shared Hospital Services

AMS

2.44 USD

Myomo, Inc. logo

Myomo, Inc.

MYO

2.89 USD

Financials

Numbers are in millions USD

Numbers are in millions USD